5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas.-论文-万方医学网

作者： Feng,Zhang ^[1] ; Yifan,Liu ^[2] ; Zhiwen,Zhang ^[1] ; Jie,Li ^[1] ; Yi,Wan ^[3] ; Liying,Zhang ^[1] ; Yangmei,Wang ^[1] ; Xia,Li ^[1] ; Yuqiao,Xu ^[1] ; Xin,Fu ^[1] ; Xiumin,Zhang ^[1] ; Ming,Zhang ^[4] ; Zhekai,Zhang ^[4] ; Jing,Zhang ^[1] ; Qingguo,Yan ^[1] ; Jing,Ye ^[1] ; Zhe,Wang ^[1] ; Charlie Degui,Chen ^[2] ; Wei,Lin ^[5] ; Qing,Li ^[1]

作者单位： State Key Laboratory of Cancer Biology, Department of Pathology; Xijing Hospital, Fourth Military Medical University, Shaanxi, 710032, China. ^[1] State Key Laboratory of Molecular Biology, Shanghai Key laboratory of Molecular Andrology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China. ^[2] Department of Health Statistics, Fourth Military Medical University, Shaanxi, 710032, China. ^[3] Company 13, Student Brigade, Fourth Military Medical University, Xi'an, 710032, China. ^[4] Department of Neurosurgery; Xijing Hospital, Fourth Military Medical University, Shaanxi, 710032, China. ^[5]

主题词 5-甲基胞嘧啶(5-Methylcytosine);青少年(Adolescent);成年人(Adult);老年人(Aged);抗体(Antibodies);星形细胞瘤(Astrocytoma);脑(Brain);中枢神经系统肿瘤(Central Nervous System Neoplasms);胞嘧啶(Cytosine);女(雌)性(Female);人类(Humans);免疫组织化学(Immunohistochemistry);异柠檬酸脱氢酶(Isocitrate Dehydrogenase);Ki-67抗原(Ki-67 Antigen);男(雄)性(Male);中年人(Middle Aged);突变(Mutation);预后(Prognosis);脊髓(Spinal Cord);存活率分析(Survival Analysis)

DOI 10.1038/srep20882

PMID 26864347

发布时间 2018-11-13

检索历史清除

5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas.

Scientific reports

相似文献

Scientific reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas.

Scientific reports

相似文献

Scientific reports

相关期刊

检索历史清除